Anxiolytic-like effect of Rauvolfia ligustrina Willd. ex Roem. & Schult., Apocynaceae, in the elevated plus-maze and hole-board tests

Revista Brasileira de Farmacognosia

Volumn 19, Issue 4, 2009, Pages 888-892

  Netto, Sueli Mendonça ^a   Warela, Rogério W B ^b   Fechine, Madge F ^b   Queiroga, Marcelo N ^b   Quintans Júnior, Lucindo J ^c  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^c FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

Anxiolytic; Apocynaceae; Hole board test; Medicinal plant; Plus maze; Rauvolfia ligustrina

Indexed keywords

ALCOHOL; DIAZEPAM; PLANT EXTRACT; RAUVOLFIA LIGUSTRINA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANXIETY; APOCYNACEAE; APPARATUS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEAD; MALE; MAZE TEST; MEDICINAL PLANT; NONHUMAN; PLANT ROOT; RAT; RAUVOLFIA LIGUSTRINA; RODENT; TRANQUILIZING ACTIVITY;

EID: 77949506986     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0102-695X2009000600017     Document Type: Article

References (30)

1. Almeida RN, Diniz SA, Diniz RST, Quintans-Júnior LJ, Barbosa-Filho JM 2000. Avaliação da toxicidade aguda e da atividade psicofarmacológica dos extratos etanólicos brutos de partes aéreas e raízes de Rauwolfia ligustrina. Livro de Resumos do XVI Simpósio de Plantas Medicinais do Brasil, R. FM194, p. 261.
2. Beaubrum G, Gray GE 2000. A review of herbal medicines for psychiatric disorder. Psychiatr Serv 51: 1130-1134.
3. Boissier JR, Simon P 1962. La reaction de exploration chez la souris. Therapie 17: 1225-1232.
4. Boissier JR, Simon P 1964. Dissociation de deux composantes dans le compartment dinvestigation de la souris. Arch Int Phamacod T 147: 372-387.
5. Cancelieri NM, Vieira IJC, Schripsema J, Mathias L, Braz-Filho R 2002. Darcybeirine, a novel pentacyclic indole alkaloid from Rauwolfia grandiflora Mart. Tetrahedron Lett 43: 1783-1787.
6. Carlini EA 2003. Plants and the central nervous system. Pharmacol Biochem Be 75: 501-512.
7. Costa-Campos L, Dassoler SC, Rigo AP, Iwu M, Elisabetsky E 2004. Anxiolytic properties of the antipsychotic alkaloid alstonine. Pharmacol Biochem Be 77: 481-489.
8. Drapier D, Bentué-Ferrer D, Lavoille B, Millet B, Allain H, Bourin M, Raymann JM 2007. Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behav Brain Res 176: 202-209.
9. Graeff FG 2000. Medicamentos Ansiolíticos. In: Graeff FG, Guimarães FS (Eds) Fundamentos de Psicofarmacologia. São Paulo: Atheneu, p. 135.
10. Handley S 1991. Serotonin in animal model of anxiety: the importance of stimulus and response. In: Cowen P, Idzikowski C (Eds) Serotonin, sleep and mental disorder. Petersfield: Wrighston, p. 89-115.
11. Handley S, McBlane JW 1993. 5-HT drugs in animal models of anxiety. Psychopharmacology 112: 13-20.
12. Kato L, Braga RM, Koch I, Kinoshita LS 2002. Indole alkaloids from Rauvolfia bahiensis A.DC. (Apocynaceae). Phytochemistry 60: 315-320.
13. Lednicer D, Mitscer LA 1977. The Organic Chemistry of Drug Synthesis. New York: John Wiley and Sons.
14. Lister RG 1987. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92: 180-185
15. Mendonça Netto S, Guimarães FSG 1996. Role of hippocampal 5-HT1A receptors on elevated plus maze exploration after a single experience. Behav Brain Res 77: 215-218.
16. Moura MDB, Agra MF 1989. Apocynaceae tóxicas e medicinais ocorrentes nos estados de Pernambuco e Paraíba. Acta Bot Bras 3: 273-79.
17. Neuss R 1970. Chemistry of the alkaloids. Van Nortrand Reinhold Company S.W. Pelletier, p. 213-226.
18. Netto SM, Silveira R, Coimbra NC, Joça SLR, Guimarães FSG 2002. Anxiogenic Effect of Median Rafe Nucleus lesion in Stressed Rats. Prog Neuro-Psychoph 26: 1135-41.
19. Pellow S, Chopin P, File SE, Briley M 1985. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 14: 149-167.
20. Pellow S, File SE 1986. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Be 24: 525-529.
21. Quintans-Júnior LJ, Almeida RN, Falcão ACGM, Agra MF, Sousa MFV, Barbosa-Filho JM 2002. Avaliação da atividade anticonvulsivante de plantas do nordeste brasileiro. Acta Farm Bonaer 21: 179-184.
22. Quintans-Júnior LJ, Silva DA, Siqueira JS, Souza MFV, Barbosa-Filho JM, Almeida RN, Silva Júnior RGC 2007. Anticonvulsant properties of the total alkaloid fraction of Rauvolfia ligustrina Roem. et Schult. in male mice. Rev Braz Farmacogn 17: 152-158.
23. Rex A, Morgenstern E, Fink H 2002. Anxiolytic-like effects of Kava-Kava in the elevated plus maze test a comparison with diazepam. Prog Neuro-Psychoph 26: 855-860.
24. Rice DP, Miller LS 1998. Health economics and cost implications of anxiety and other mental disorders in the United States. Brit J Psychiat 173: 4-9.
25. Salchner P, Singewald N 2002. Neuroanatomical substrates involved in the anxiogenic-like effect of acute fluoxetine treatment. Neuropharmacology 43: 1238-48.
26. Seo J, Lee S, Lee Y, Kwon B, Ma Y, Hwang B, Hong J, Wan OK 2007. Anxiolytic-like effects of obovatol isolated from Magnolia obovata: Involvement of GABA/benzodiazepine receptors complex. Prog Neuro-Psychoph 31: 1363-1369.
27. Silva AL, Elisabetsky E 2001. Inferences of propylene glycol with the hole-board test. Braz J Med Biol Res 34: 545-547.
28. Takeda H, Tsuji M, Matsumiya T 1998. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur J Pharmacol 350: 21-29.
29. Wittchen HU, Hoyer J 2001. Generalized anxiety disorder: nature and course. J Clin Psychiat 62: 15-21.
30. st ed., 1-11.